Gabelli & Co Investment Advisers’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,800
Closed -$214K 279
2023
Q1
$214K Buy
+20,800
New +$214K 0.04% 149